Coronavirus Disease-2019 and Stroke: Pathophysiology and Management.
Coulter N SmallYusuf MehkriEric PantherPatrick FelismaBrandon Lucke-WoldPublished in: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques (2022)
Severe acute respiratory syndrome coronavirus 2, the virus that causes coronavirus disease-2019, has been associated with an increased risk for ischemic and hemorrhagic stroke. As data emerge about the underlying mechanisms, it is important to synthesize current knowledge to improve effective treatment options. In this review, we highlight the known pathophysiology, discuss the relationship between ischemic and hemorrhagic stroke, and address emerging implications for patient management. The information here is compiled to be a user-friendly, quick guide to help practitioners select management options for these patients.
Keyphrases
- coronavirus disease
- respiratory syndrome coronavirus
- atrial fibrillation
- sars cov
- cerebral ischemia
- end stage renal disease
- healthcare
- primary care
- newly diagnosed
- ischemia reperfusion injury
- peritoneal dialysis
- electronic health record
- artificial intelligence
- big data
- social media
- patient reported outcomes
- health information
- general practice
- patient reported